Transcriptional Behavior of Regulatory T Cells Predicts IBD Patient Responses to Vedolizumab Therapy.
Maria T AbreuJulie M DaviesMaria A QuinteroAmber DelmasSophia DiazCatherine D MartinezThomas VenablesAdrian ReichGogce CrynenAmar R DeshpandeDavid H KermanOriana M DamasIrina FernandezAna M SantanderJudith Pignac-KobingerJuan F BurguenoMark S SundrudPublished in: Inflammatory bowel diseases (2022)
Mucosal and peripheral blood immune cell phenotypes and transcriptional profiles can inform VDZ efficacy and inform new opportunities for combination therapies.